Stay updated with breaking news from Williama hagopian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost-effectively identify those at risk who could potentially receive it. ....